trending Market Intelligence /marketintelligence/en/news-insights/trending/4cdfprfhixc0y-8r9tigva2 content esgSubNav
In This List

Chembio Diagnostics adds director to board

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Chembio Diagnostics adds director to board

Medford, N.Y.-based Chembio Diagnostics Inc., a healthcare supplies company, appointed Mary Polan as director.

Polan is director of Quidel Corp. and Motif BioSciences Inc.

Chembio Diagnostics and its units develop, manufacture and commercialize point-of-care diagnostic tests used to detect or monitor diseases.